BKG Pharma is a privately held Danish biopharmaceutical company exclusively committed to the development of novel antibiotics against multidrug-resistant (MDR) bacteria. We kill superbugs for a living. 

Through our groundbreaking research and development program we have identified and developed an entire new class of small molecule antibiotics with a novel mechanism of action independent of all known resistance mechanism.